Short-term Intraocular Pressure Changes Immediately After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents

American Journal of Ophthalmology

Volumn 146, Issue 6, 2008, Pages

  Kim, Judy E ^a   Mantravadi, Anand V ^a   Hur, Elizabeth Y ^a   Covert, Douglas J ^a  

^a EYE INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; PEGAPTANIB; RANIBIZUMAB; TRIAMCINOLONE ACETONIDE; VASCULOTROPIN INHIBITOR;

ADULT; AGED; ARTICLE; FEMALE; HAND MOVEMENT; HUMAN; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; OPHTHALMOSCOPY; OPTIC NERVE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; VISION;

EID: 56249105395     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.07.007     Document Type: Article

References (13)

1. Rosenfeld P.J., Brown D.M., Heier J.S., et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355 (2006) 1419-1431
2. Jager R.D., Aiello L.P., Patel S.C., and Cunningham Jr. E.T. Risks of intravitreous injection: a comprehensive review. Retina 24 (2004) 676-698
3. Aiello L.P., Brucker A.J., Chang S., et al. Evolving guidelines for intravitreous injections. Retina 24 (2004) S3-S19
4. Gragoudas E.S., Adamis A.P., Cunningham Jr. E.T., et al., VEGF inhibition study in ocular neovascularization clinical trial group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 351 (2004) 2805-2816
5. Hariprasad S.M., Shah G.K., and Blinder K.J. Short-term intraocular pressure trends following intravitreal pegaptanib (Macugen) injection. Am J Ophthalmol 141 (2006) 200-201
6. Lee E.W., Hariprasad S.M., Mieler W.F., Newman T.L., and Apte R.S. Short-term intraocular pressure trends after intravitreal triamcinolone injection. Am J Ophthalmol 143 (2007) 365-367
7. Falkenstein I.A., Cheng L., and Freeman W.R. Changes of intraocular pressure after intravitreal injection of bevacizumab (Avastin). Retina 27 (2007) 1044-1047
8. Hollands H., Wong J., Bruemn R., Campbell R.J., Sharma S., and Gale J. Short-term intraocular pressure changes after intravitreal injection of bevacizumab. Can J Ophthalmol 42 (2007) 807-811
9. Kotliar K., Maier M., Bauer S., Feucht N., Lohmann C., and Lanzl I. Effect of intravitreal injections and volume changes on intraocular pressure: clinical results and biomechanical model. Acta Ophthalmol Scand 85 (2007) 777-781
10. Benz M.S., Albini T.A., Holz E.R., et al. Short-term course of intraocular pressure after intravitreal injection of triamcinolone acetonide. Ophthalmology 113 (2006) 1174-1178
11. Bakri SJ, Pulido JS, McCannel CA, Hodge DO, Diehl N, Hillemeier J. Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab. Eye. Forthcoming.
12. Van der Jagt L.H., and Jansonius N.M. Three portable tonometers, the TGDc-01, the ICARE and the Tonopen XL, compared with each other and with Goldmann applanation tonometry. Ophthalmic Physiol Opt 25 (2005) 429-435
13. Lim K.S., Wickremasinghe S.S., Cordeiro M.F., Bunce C., and Khaw P.T. Accuracy of intraocular pressure measurements in New Zealand white rabbits. Invest Ophthalmol Vis Sci 46 (2005) 2419-2423